OLIG2 expression level could be used as an independent prognostic factor for patients with cerebellar Glioblastoma (cGBM). Clinics [Internet]. 2023 Mar. 30 [cited 2024 May 9];78:100120. Available from: https://www.journals.usp.br/clinics/article/view/213766